Autologous hematopoietic cell transplantation in diffuse large B-cell lymphoma after three or more lines of prior therapy: evidence of durable benefit

• Matthew Mei,
• Mehdi Hamadani,
• Kwang W. Ahn,
• Yue Chen,
• Mohamed A. Kharfan-Dabaja,
• Craig Sauter,
• Alex F. Herrera

Affiliations

Matthew Mei

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

Mehdi Hamadani

BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Kwang W. Ahn

Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI; Center for International Blood and Marrow Transplant Research, Milwaukee, WI

Yue Chen

Center for International Blood and Marrow Transplant Research, Milwaukee, WI

Mohamed A. Kharfan-Dabaja

Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL

Craig Sauter

BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Alex F. Herrera

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA